Compounds > 3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid
Page last updated: 2024-08-26

3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid and aniracetam

3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid has been researched along with aniracetam in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
al-Zubaidy, Z; Chapman, AG; Meldrum, BS1

Other Studies

1 other study(ies) available for 3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid and aniracetam

ArticleYear
Aniracetam reverses the anticonvulsant action of NBQX and GYKI 52466 in DBA/2 mice.
    European journal of pharmacology, 1993, Feb-09, Volume: 231, Issue:2

    Topics: Acoustic Stimulation; Animals; Anti-Anxiety Agents; Anticonvulsants; Benzodiazepines; Dose-Response Relationship, Drug; Mice; Mice, Inbred DBA; Piperazines; Pyrrolidinones; Quinoxalines; Receptors, N-Methyl-D-Aspartate; Seizures

1993